What does the latest research say about the benefits of GLP-1 drugs? episode artwork

EPISODE · Sep 11, 2025 · 24 MIN

What does the latest research say about the benefits of GLP-1 drugs?

from The Dose

GLP-1 drugs like Ozempic are proven effective for type 2 diabetes and weight management. Researchers are now exploring their potential to reduce heart, kidney, liver, and even Alzheimer’s disease risks. But experts, including obesity specialist Dr. Sean Wharton, warn against off-label use. He breaks down the latest research and what the future might hold.For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Episode metadata supplied by the publisher feed · Published Sep 11, 2025

Embed this episode

NOW PLAYING

What does the latest research say about the benefits of GLP-1 drugs?

0:00 24:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Dose?

This episode is 24 minutes long.

When was this The Dose episode published?

This episode was published on September 11, 2025.

Can I download this The Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!